Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India.
Nirmalkumar ChorariaSavita RangarajanM Joseph JohnShashikant AptePritam GuptaSeema PaiRohit ChandShyam ParvatiniG S H RamakanthJeremy RuponAmit ChhabraHitesh Bhaskarrao MuleyDamien SimoneauPublished in: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion (2022)
Moroctocog alfa was safe, effective, and well tolerated in Indian participants with congenital moderate to severe hemophilia A. No participant developed FVIII inhibitors during the study.